`
`MEMW
`
`mmm
`
`
`
`
`
`
`
`For additional lnforrnation about the
`
`REVLIMID REMS° program, please
`contact the Celgene Customer Care
`Center at 1 688-423-5436
`
`Download the Celgene REMS
`mobile app to your lPad by clicking
`here:
`I l l.vt»ll m n-
`
`. App Store
`
`
`
`Welcome to the REVLIMID REMS® program
`REVLIMIDo (lenalldomlde) In combination with dexamethasone is indicated for the treatment of patients with
`multiple myeloma (MM).
`
`REVLIMID is Indicated as maintenance therapy in patients with MM following autologous hematopoietlc stem cell
`transplantation (aub—HSCT).
`
`REVLIMID is indicated for the treatment of patients with transfusion-dependent anemia due to low- or
`Inhrmedlate-1—risk myelodysplastlc syndromes (MDS) associated with a deletion Sq cytogenetlc abnormality with
`or without additional cytogenetlc abnorrnalitles.
`
`REVLIMID is Indicated for the treatment of patients with mantle cell lymphoma (MCL) whose disease has
`relapsed or progressed after two prior therapies, one of which included bortezomib.
`
`important information about REVLIMID and the REVLIMID Risk Evaluation
`and Mitigation Strategy (REMS) program
`
`- REVLIMID is contraindicated in pregnant females and females capable of becoming pregnant. Females of
`reproductive potential may be treated with REVUMID provided adequate precautions are taken to avoid
`pregnancy
`- To avoid embryo-fetal exposure, REVLIMID is only available undera restricted distribution program called
`"REVLIMID REMSO”
`
`- Only prescribers and pharmacies certified by the REVLIMID REMSO program can prescribe and dspense
`REVLIMID to patients who are enrolled and meet all the conditions of the REVLIMID REMS" program
`
`The goals of the REVUMID risk evaluation and mitigation strategy are as follows:
`1. To prevent the risk of embryo-btal exposure to REVUMID
`2. To lnfonn prescribers, patients, and pharmacists on the serious risks and sale-use conditions for REVLIMID
`
`Privacy policy
`
`I Tenneof Use
`
`I Site My:
`
`I Contactue
`
`REVLIMIDo and REVLIMID REMS° are registered trademarks of Celgene Corporation.
`© 2013-2017. Celgene Corporation,Wm
`This website is intended for residents of the United States only.
`
`http:/Mw.revllmidrems.cornl
`
`1/1
`
`DR. REDDY’S LABS., INC. EX. 1070 PAGE 1
`
`DR. REDDY’S LABS., INC. EX. 1070 PAGE 1
`
`